PL3400000T3 - Sposoby podawania angiotensyny ii - Google Patents
Sposoby podawania angiotensyny iiInfo
- Publication number
- PL3400000T3 PL3400000T3 PL17736407.2T PL17736407T PL3400000T3 PL 3400000 T3 PL3400000 T3 PL 3400000T3 PL 17736407 T PL17736407 T PL 17736407T PL 3400000 T3 PL3400000 T3 PL 3400000T3
- Authority
- PL
- Poland
- Prior art keywords
- methods
- administering angiotensin
- angiotensin
- administering
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
- G01N2410/02—Angiotensins; Related peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662276171P | 2016-01-07 | 2016-01-07 | |
| US201662347292P | 2016-06-08 | 2016-06-08 | |
| PCT/US2017/012485 WO2017120438A1 (en) | 2016-01-07 | 2017-01-06 | Methods for administering angiotensin ii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3400000T3 true PL3400000T3 (pl) | 2024-04-22 |
Family
ID=59273945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17736407.2T PL3400000T3 (pl) | 2016-01-07 | 2017-01-06 | Sposoby podawania angiotensyny ii |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US10406201B2 (pl) |
| EP (1) | EP3400000B1 (pl) |
| JP (1) | JP2019501201A (pl) |
| KR (2) | KR20180108639A (pl) |
| AU (2) | AU2017205168A1 (pl) |
| BR (1) | BR112018013847A2 (pl) |
| CA (1) | CA3010781A1 (pl) |
| ES (1) | ES2973280T3 (pl) |
| PL (1) | PL3400000T3 (pl) |
| TW (1) | TW201733610A (pl) |
| WO (1) | WO2017120438A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9572856B2 (en) | 2009-12-16 | 2017-02-21 | The George Washington University a Congressionally Chartered Not-for-Profit Corporation | Method of treating low blood pressure |
| LT2986308T (lt) | 2013-12-18 | 2020-03-25 | The George Washington University, A Congressionally Chartered Not-For-Profit Corporation | Angiotenzino ii derinys hipotenzijai gydyti |
| PL3400000T3 (pl) | 2016-01-07 | 2024-04-22 | La Jolla Pharma, Llc | Sposoby podawania angiotensyny ii |
| WO2018191678A1 (en) | 2017-04-14 | 2018-10-18 | La Jolla Pharmaceutical Company | Methods for administering angiotensin ii |
| WO2021092057A1 (en) * | 2019-11-04 | 2021-05-14 | The Regents Of The University Of California | Artificial intelligence enabled control of hemodynamics in surgery patients |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU181008B (en) | 1980-01-18 | 1983-05-30 | Richter Gedeon Vegyeszet | Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position |
| US5216025A (en) | 1989-09-13 | 1993-06-01 | Board Of Regents, The University Of Texas System | Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| US5444067A (en) | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
| CA2448051A1 (en) | 2001-06-04 | 2002-12-12 | Human Genome Sciences, Inc. | Methods and compositions for modulating ace-2 activity |
| US7115266B2 (en) | 2001-10-05 | 2006-10-03 | Cytos Biotechnology Ag | Angiotensin peptide-carrier conjugates and uses thereof |
| NO20034952D0 (no) | 2003-11-06 | 2003-11-06 | Amersham Health As | Farmasöytiske forbindelser |
| JP2007510643A (ja) | 2003-11-06 | 2007-04-26 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | 医薬化合物 |
| EP1942985B1 (en) | 2005-09-29 | 2011-04-27 | Fibrogen, Inc. | Methods for reducing blood pressure |
| WO2007076572A1 (en) | 2005-12-30 | 2007-07-12 | Howard Florey Institute Of Experimental Physiology And Medicine | A method of treatment |
| EP2029137A2 (en) * | 2006-06-15 | 2009-03-04 | Gilead Colorado, Inc. | Antihypertensive therapy method |
| CA2678131A1 (en) | 2006-11-17 | 2008-05-22 | Antoine Andremont | Colonic delivery using zn/pectin beads with a eudragit coating. |
| AU2009319856A1 (en) | 2008-11-28 | 2010-06-03 | Abbvie Inc. | Stable antibody compositions and methods for stabilizing same |
| US9572856B2 (en) * | 2009-12-16 | 2017-02-21 | The George Washington University a Congressionally Chartered Not-for-Profit Corporation | Method of treating low blood pressure |
| BR112013000744A2 (pt) | 2010-07-14 | 2020-07-14 | Cumberland Emerging Technologies, Inc | uso de um antagonista de receptor de tromboxana a2 para prevenção ou tratamento de síndrome hepatorrenal,encefalopatia hepática,e doenças associadas |
| JP6522584B2 (ja) | 2013-04-26 | 2019-05-29 | ラ ホヤ ファーマシューティカル カンパニーLa Jolla Pharmaceutical Company | 腎不全を処置するための組成物及び方法 |
| LT2986308T (lt) | 2013-12-18 | 2020-03-25 | The George Washington University, A Congressionally Chartered Not-For-Profit Corporation | Angiotenzino ii derinys hipotenzijai gydyti |
| US20150286797A1 (en) | 2014-04-02 | 2015-10-08 | David R. Ratto | System and method for administering medication |
| EP3381465A1 (en) | 2014-07-08 | 2018-10-03 | La Jolla Pharmaceutical Company | Methods for treating hypotension |
| WO2017120440A1 (en) | 2016-01-07 | 2017-07-13 | La Jolla Pharmaceutical Company | Methods of administering vasopressors |
| PL3400000T3 (pl) | 2016-01-07 | 2024-04-22 | La Jolla Pharma, Llc | Sposoby podawania angiotensyny ii |
| WO2018191678A1 (en) | 2017-04-14 | 2018-10-18 | La Jolla Pharmaceutical Company | Methods for administering angiotensin ii |
| TW201927331A (zh) | 2017-12-15 | 2019-07-16 | 美商拉荷亞製藥公司 | 血管收縮素組合物及與其相關之方法 |
-
2017
- 2017-01-06 PL PL17736407.2T patent/PL3400000T3/pl unknown
- 2017-01-06 JP JP2018535412A patent/JP2019501201A/ja active Pending
- 2017-01-06 ES ES17736407T patent/ES2973280T3/es active Active
- 2017-01-06 US US15/400,275 patent/US10406201B2/en active Active
- 2017-01-06 AU AU2017205168A patent/AU2017205168A1/en not_active Abandoned
- 2017-01-06 TW TW106100418A patent/TW201733610A/zh unknown
- 2017-01-06 KR KR1020187022269A patent/KR20180108639A/ko not_active Ceased
- 2017-01-06 EP EP17736407.2A patent/EP3400000B1/en active Active
- 2017-01-06 KR KR1020257040302A patent/KR20250174727A/ko active Pending
- 2017-01-06 WO PCT/US2017/012485 patent/WO2017120438A1/en not_active Ceased
- 2017-01-06 CA CA3010781A patent/CA3010781A1/en active Pending
- 2017-01-06 BR BR112018013847A patent/BR112018013847A2/pt not_active Application Discontinuation
-
2020
- 2020-03-26 US US16/831,182 patent/US20210030834A1/en not_active Abandoned
-
2021
- 2021-03-04 US US17/192,453 patent/US11219662B2/en active Active
-
2024
- 2024-02-19 AU AU2024201059A patent/AU2024201059A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2973280T3 (es) | 2024-06-19 |
| US20210030834A1 (en) | 2021-02-04 |
| US20170224761A1 (en) | 2017-08-10 |
| AU2024201059A1 (en) | 2024-03-07 |
| JP2019501201A (ja) | 2019-01-17 |
| US20210187058A1 (en) | 2021-06-24 |
| CA3010781A1 (en) | 2017-07-13 |
| BR112018013847A2 (pt) | 2018-12-18 |
| US11219662B2 (en) | 2022-01-11 |
| US10406201B2 (en) | 2019-09-10 |
| WO2017120438A1 (en) | 2017-07-13 |
| EP3400000B1 (en) | 2023-12-06 |
| EP3400000A1 (en) | 2018-11-14 |
| EP3400000A4 (en) | 2019-07-31 |
| KR20180108639A (ko) | 2018-10-04 |
| KR20250174727A (ko) | 2025-12-12 |
| TW201733610A (zh) | 2017-10-01 |
| AU2017205168A1 (en) | 2018-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201802794PA (en) | Therapeutic compounds and methods | |
| SG10201912416QA (en) | Therapeutic agents | |
| PT3132034T (pt) | Terapêutica | |
| GB201509893D0 (en) | Therapeutic agents | |
| GB201616839D0 (en) | Therapeutic compounds | |
| GB201517263D0 (en) | Therapeutic agents | |
| GB201410816D0 (en) | Therapeutic agents | |
| GB201415569D0 (en) | Therapeutic Compounds | |
| ZA201805046B (en) | Therapeutic compounds | |
| GB201410216D0 (en) | Therapeutic | |
| GB201509885D0 (en) | Therapeutic agents | |
| GB201410817D0 (en) | Therapeutic agents | |
| GB201410815D0 (en) | Therapeutic agents | |
| PL3400000T3 (pl) | Sposoby podawania angiotensyny ii | |
| GB201509888D0 (en) | Therapeutic agents | |
| GB201617339D0 (en) | Therapeutic compounds | |
| IL263821A (en) | Medicinal compounds | |
| GB201513299D0 (en) | Therapeutic agents | |
| GB201510637D0 (en) | Therapeutic | |
| GB201416273D0 (en) | Therapeutic compounds | |
| GB2538767B (en) | Coffin | |
| GB201521767D0 (en) | Therapeutic agents | |
| SG11201700059WA (en) | Therapeutic agent for keratoconjunctive disorder | |
| GB201517264D0 (en) | Therapeutic agents | |
| GB201410334D0 (en) | Therapeutic |